Parastremmatic dwarfism

Lore & Background

The mutation occurs within the N-ankyrin domain of TRPV4, which is involved in regulation of the TRPV4 calcium ion channel. This calcium influx may be responsible for neuronal cell death and may affect levels of circulating growth hormones. As of 2011, only five people worldwide had been diagnosed with parastremmatic dwarfism, making functional analysis elusive.

Reader's Guide

Parastremmatic dwarfism is significant as a rare skeletal dysplasia that illustrates the link between a specific genetic mutation and severe bone and joint deformities. Its identification by Leonard Langer and associates in 1970 provided a distinct clinical and radiographic entity, characterized by a flocky or lace-like appearance of bones on X-ray. The discovery of the R594H mutation in the TRPV4 gene, also implicated in Kozlowski spondylometaphyseal dysplasia, highlights the pleiotropic effects of mutations in this calcium channel gene. The extreme rarity of the condition—only five diagnosed cases as of 2011—limits comprehensive study, but the genetic findings contribute to understanding of TRPV4-related disorders and the role of calcium signaling in skeletal development. The autosomal dominant inheritance pattern informs genetic counseling for affected families. The disease's congenital nature and progressive skeletal deformities underscore the need for early diagnosis and supportive management, though treatment options remain limited due to the scarcity of cases.

Did You Know?

• The term parastremmatic comes from the Greek parastremma, meaning distorted limbs.
• On X-rays, the disease is distinguished by a flocky or lace-like appearance to the bones.
• The R594H mutation in the TRPV4 gene is specifically associated with parastremmatic dwarfism, not the Kozlowski type of spondylometaphyseal dysplasia, which is caused by different mutations such as K616Q or R594C.